Semantic Scholar uses AI to extract papers important to this topic.
To assess both the acceptance and the discontinuation rates from dapoxetine, the first oral pharmacological agent… Expand Premature ejaculation (PE) is a common male sexual disorder which is associated with substantial personal and interpersonal… Expand INTRODUCTION
Dapoxetine has been evaluated for the on-demand treatment of premature ejaculation (PE) in five phase 3 studies in… Expand CONTEXT
Erectile dysfunction (ED) and premature ejaculation (PE) are the two most prevalent male sexual dysfunctions.
OBJECTIVE… Expand INTRODUCTION
Dapoxetine is a short-acting selective serotonin reuptake inhibitor that was recently approved for the on-demand… Expand BACKGROUND
Dapoxetine is being developed for the on-demand treatment of premature ejaculation (PE). Previous clinical trials have… Expand To evaluate the reliability and validity of the Premature Ejaculation Profile (PEP), a self‐reported outcome instrument for… Expand To evaluate the overall treatment benefit of dapoxetine for premature ejaculation (PE), with specific emphasis on improvements in… Expand BACKGROUND
No drugs are approved for treatment of premature ejaculation. Our aim was to determine the efficacy and tolerability… Expand Potential pharmacokinetic interactions between dapoxetine, a serotonin transporter inhibitor developed for the treatment of… Expand